Science
Mechanism of Action
This antifungal agent functions by inhibiting the fungal enzyme lanosterol 14-alpha-demethylase, which is vital for the biosynthesis of ergosterol. Ergosterol is a critical component of fungal cell membranes; its disruption compromises membrane integrity and permeability, ultimately leading to fungal cell death.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 A maximally soluble topical formulation failed to achieve therapeutic concentrations in epidermal tumors during human trials for basal cell carcinoma, indicating poor penetration or efficacy for this condition.
- 02 Used as a control in an ethanol solution for a mouse study evaluating optimized formulations, demonstrating its baseline efficacy against superficial mycosis in that context, though the optimized formulation showed enhanced performance.
Transparency
Dusting Analysis
Itraconazole is an FDA-approved prescription antifungal medication, not a common ingredient in cosmetic formulations. Therefore, the concept of 'dusting' does not apply to this pharmaceutical compound.
The Formula
Formulation
Stability
Itraconazole is a weak base with a pKa of 3.7 and exhibits pH-dependent solubility, being highly sensitive to pH variations. Its dissolution rate significantly decreases with even a slight increase in pH from 1.2 to 2.0. The raw drug substance is stable to heat, light, acid, and alkali, but is susceptible to oxidation.
Conflicts
- Extensive systemic drug interactions occur when administered orally, as itraconazole acts as a CYP3A4 substrate and inhibitor, and a P-glycoprotein substrate.
- Concerns exist regarding topical fixed-drug combinations, particularly with potent corticosteroids and antibacterial agents, which can lead to hazardous outcomes and the rapid development of itraconazole resistance.
Safety
Safety Profile
Itraconazole is an FDA-approved prescription drug for systemic and superficial fungal infections, and is not typically reviewed by cosmetic safety panels like CIR or SCCS. There are significant concerns that topical formulations as a single molecule or in fixed-drug combinations may foster rapid drug resistance. Oral administration is associated with serious potential side effects, including hepatotoxicity and congestive heart failure.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Itraconazole is a potent prescription antifungal, but its pharmaceutical nature, potential to induce resistance, and lack of cosmetic safety review make its inclusion in non-drug cosmetic formulations highly questionable.
Related
Similar Ingredients
Finding similar ingredients…